Evidence map›Paper›PMID 41194423›Full record

ReviewAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

Microvascular Health as a Key Determinant of Organismal Aging.

Mattia Cenciarini, Andrea Uccelli, Francesca Mangili, Myriam Grunewald, Simone Bersini

Abstract readReview
In one paragraph

Review in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Decoding Vascular Senescence: Cellular Insights and Therapeutic Strategies.International journal of biological sciences · 2026
    Review
  5. Microvascular Health as a Key Determinant of Organismal Aging.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mattia CenciariniRegenerative Medicine Division, Institute for Translational Research (IRT), Faculty of Biomedical Sciences, Università della Svizzera italiana (USI) and Ente Ospedaliero Cantonale (EOC), Bellinzona, 6500, Ticino, Switzerland.
Andrea UccelliRegenerative Medicine Division, Institute for Translational Research (IRT), Faculty of Biomedical Sciences, Università della Svizzera italiana (USI) and Ente Ospedaliero Cantonale (EOC), Bellinzona, 6500, Ticino, Switzerland.
Francesca MangiliIstituto Dalle Molle di Studi sull'Intelligenza Artificiale (IDSIA), SUPSI, Lugano, 6900, Ticino, Switzerland.
Myriam GrunewaldFaculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, 9190500, Israel.
Simone BersiniRegenerative Medicine Division, Institute for Translational Research (IRT), Faculty of Biomedical Sciences, Università della Svizzera italiana (USI) and Ente Ospedaliero Cantonale (EOC), Bellinzona, 6500, Ticino, Switzerland.ORCID https://orcid.org/0000-0003-4620-3500

Funding

Fondation Suisse de Recherche sur les Maladies MusculairesNovartis Forschungsstiftung (FreeNovation Program)Novartis Foundation for medical-biological researchSwiss National Science Foundation 320030-231755Swiss State Secretariat for Education, Research and Innovation MB22.00085
6 · The paper itself

Abstract

Aging is a complex, multifaceted process affecting all organ systems, with vascular aging playing a central role in organismal health decline. Beyond its role in circulation, the vascular system acts as a dynamic interface between tissues, influencing countless physiological functions such as tissue regeneration and repair, immune responses, and metabolic balance. Importantly, age-related vascular impairment-characterized by a peculiar set of endothelial aging hallmarks-exacerbates age-related diseases (ARDs) such as cardiovascular disorders, neurodegeneration, chronic kidney disease, sarcopenia, and osteoporosis. This review combines basic concepts of angioscience and aging biology with translational interventions to devise clinical strategies promoting a functional rejuvenation of old and compromised blood vessels, fostering the prevention, delay or treatment of ARDs. Starting from the description of the cellular and molecular mechanisms driving vascular aging, a cutting-edge perspective on the organ-specific vascular impairment and its impact on tissue function is offered. Given the central role of the vasculature in aging, how targeting vascular aging through pharmacological, genetic, and lifestyle interventions holds promise for mitigating its systemic consequences and improving healthspan is discussed. Finally, how the combination of animal models (e.g., parabiosis) and novel microphysiological systems, coupled with multi-omics and artificial intelligence-driven analyses, is advancing the field toward the identification of strategies that promote vascular resilience and extend healthspan, addressing one of the most pressing biomedical challenges of a worldwide aging population is highlighted.

Indexed as

AgingMicrovesselsAnimalsHumanslongevity medicineOrgan‐on‐a‐Chipvascular aging mechanismsvascular healthvascular rejuvenation

Identifiers

PMID41194423
PMCPMC12713109

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.